ADR News Bulletin 2011 December (Volume 13 Number 3)

Bulletin Highlights:

• Reports of lymphadenitis following administration of BCG Vaccine SSI®

• Voluntary worldwide recall of drotrecogin alfa (Xigris®)

• Birth defects in infants associated with in utero exposure to long-term, high-dose fluconazole

• Recent Product Safety-related articles published on HSA website

• Bleeding events associated with dabigatran etexilate (Pradaxa®)

• Updates on adulterated health products reported to HSA

• Suspension of the sales of Zerin® (paracetamol) tablets

• Summary of safety advisories issued by HSA, pharmaceutical and medical device companies

• Voluntary recall of Bayer Contour™ TS blood glucose test strips in Singapore

• HSA’s advisory on the use of the ID-Micro Typing System test cell reagent ID-DiaCell I-II-III

• HSA’s advisory on the use of pioglitazone

Click on the link below to download the issue in pdf:

ADR_News_Dec2011_Vol13_No3 [PDF, 445 KB]